A Phase 3, Open-label Study of Adjunctive Ganaxolone (GNX) Treatment in Children and Adults with Tuberous Sclerosis Complex (TSC)-related Epilepsy

Project: Research

Project Details

Project Description


StatusActive
Effective start/end date19/04/24 → 19/04/26

Keywords

  • clinical trial
  • epilepsy
  • ganaxolone

Clinical Trial Phase

  • Phase III (a & b)